Senescent CD8+ T and NK cells contribute to immunopathogy duting cutaneous leishmaniasis
衰老的 CD8 T 和 NK 细胞导致皮肤利什曼病的免疫病理
基本信息
- 批准号:MR/T015853/1
- 负责人:
- 金额:$ 93.31万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2020
- 资助国家:英国
- 起止时间:2020 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Parasites belonging to the genus Leishmania are among the most diverse of human pathogens, both in terms of geographical distribution and in the variety of clinical syndromes caused by them. Currently, 12 million people are infected worldwide in 88 tropical/subtropical countries, 2 million new infections are reported annually, and 350 million people are under infection risk. In the past decade, the number of cases in endemic areas has increased sharply. In addition, leishmaniasis is spreading to several non-endemic areas of the world due to coinfections with HIV. Control measures currently available are case detection and treatment with drugs, which are expensive, not always available and cannot be self-administered. The problem is further aggravated by the surge of drug resistance parasites necessitating the development of an anti-Leishmania vaccine or other immunological therapies urgent.Research has demonstrated the importance of the immunity in controlling both cutaneous and mucocutaneous leishmaniasis, however the severe skin lesions that develop at the infected site is largely due to non-specific tissue damage but the reasons for this are unclear. The majority of this work has been performed on blood samples taken from patients and not from the site of infection at the skin. In this context, a unique feature of the current proposal is that we will be investigating the blood as well as the skin from the same patients, taken from both lesional and non-lesional sites. The main hypothesis of this grant application is that the severity of cutaneous immunopathology in infected individuals is due to non-specific damage mediated by both two types of immune cell namely the natural killer (NK) cells and a type of T cell that represent the "Dad's Army" of the immune system. Both these cell types are probably not triggered by the parasite in the skin lesions, instead they recognize decoy molecules in non-infected skin cells that cause them to be destroyed. This results in the large skin lesions that contain few parasites but huge numbers of dangerous white cells. In this study we will investigate the nature of the white cells in the skin lesions of patients. We will identify the decoy receptors that promote the non-specific tissue damage. We will also look at the wide array of genes that are activated in the skin to identify clue of how the interactions between the immune system and the skin are organized. We will also identify genes that will give us clues as to what other processes may be occurring that do not allow the lesions to resolve. In other parts of the study we will mimic the interaction of cell that are in the skin by growing them in a test tube to probe their interactions and find a way to block them. Finally we will investigate the involvement of a set off molecules known as sestrins, that we previously showed were involved in setting up the decoy mechanisms that may lead to skin lesion formation in patients with cutaneous leishmaniasis.As added value to this proposal, The Federal University of Espirito Santo will contribute 1 Technician and 1 PhD student to work on aspects of this grant.
属于利什曼原虫属的寄生虫是人类病原体中最多样化的,无论是在地理分布方面还是在由它们引起的各种临床综合征方面。目前,全世界88个热带/亚热带国家有1 200万人感染,每年报告200万新感染病例,3.5亿人面临感染风险。在过去十年中,流行地区的病例数量急剧增加。此外,由于与艾滋病毒合并感染,利什曼病正在向世界上几个非流行地区蔓延。目前可用的控制措施是病例检测和药物治疗,但费用昂贵,并非总是可用,而且不能自我管理。由于抗药性寄生虫的激增,使抗利什曼原虫疫苗或其他免疫疗法的开发成为必要,这一问题进一步恶化。研究表明,免疫在控制皮肤和皮肤粘膜利什曼病中的重要性,然而,在感染部位发生的严重皮肤病变主要是由于非特异性组织损伤,但原因尚不清楚。这项工作的大部分是在从患者身上采集的血液样本上进行的,而不是从皮肤感染部位采集的。在这种情况下,当前提案的一个独特特征是,我们将研究来自同一患者的血液和皮肤,从病变和非病变部位采集。该资助申请的主要假设是,受感染个体的皮肤免疫病理学的严重性是由于两种类型的免疫细胞介导的非特异性损伤,即自然杀伤(NK)细胞和代表免疫系统的“爸爸的军队”的T细胞。这两种细胞类型可能不是由皮肤病变中的寄生虫触发的,而是它们识别未感染皮肤细胞中的诱饵分子,导致它们被破坏。这导致了大的皮肤病变,其中含有很少的寄生虫,但大量的危险的白色细胞。在这项研究中,我们将调查的性质,白色细胞在皮肤病变的患者。我们将鉴定促进非特异性组织损伤的诱饵受体。我们还将研究皮肤中被激活的各种基因,以确定免疫系统和皮肤之间的相互作用是如何组织的。我们还将确定基因,这将为我们提供线索,以了解可能发生的其他过程,不允许病变解决。在研究的其他部分,我们将通过在试管中培养细胞来模拟皮肤中细胞的相互作用,以探测它们的相互作用并找到阻止它们的方法。最后,我们将调查的参与,一套小康分子被称为sestrins,我们以前表明参与设置的诱饵机制,可能导致皮肤利什曼病患者皮肤病变的形成。作为附加值,这项建议,圣埃斯皮里托的联邦大学将提供1名技术员和1名博士生工作的方面,这项赠款。
项目成果
期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Transcriptomic landscape of skin lesions in cutaneous leishmaniasis reveals a strong CD8+ T cell immunosenescence signature linked to immunopathology.
皮肤利什曼病皮肤病变的转录组学景观揭示了与免疫病理学相关的强烈 CD8 T 细胞免疫衰老特征。
- DOI:10.1111/imm.13410
- 发表时间:2021
- 期刊:
- 影响因子:6.4
- 作者:Fantecelle CH
- 通讯作者:Fantecelle CH
The role of senescent T cells in immunopathology.
衰老T细胞在免疫病理学中的作用。
- DOI:10.1111/acel.13272
- 发表时间:2020-12
- 期刊:
- 影响因子:7.8
- 作者:Covre LP;De Maeyer RPH;Gomes DCO;Akbar AN
- 通讯作者:Akbar AN
PD-1 Blockade Modulates Functional Activities of Exhausted-Like T Cell in Patients With Cutaneous Leishmaniasis.
- DOI:10.3389/fimmu.2021.632667
- 发表时间:2021
- 期刊:
- 影响因子:7.3
- 作者:Garcia de Moura R;Covre LP;Fantecelle CH;Gajardo VAT;Cunha CB;Stringari LL;Belew AT;Daniel CB;Zeidler SVV;Tadokoro CE;de Matos Guedes HL;Zanotti RL;Mosser D;Falqueto A;Akbar AN;Gomes DCO
- 通讯作者:Gomes DCO
Sicilian semi- and supercentenarians: identification of age-related T-cell immunophenotype to define longevity trait
- DOI:10.1093/cei/uxad074
- 发表时间:2023-12-11
- 期刊:
- 影响因子:4.6
- 作者:Ligotti,Mattia Emanuela;Accardi,Giulia;Candore,Giuseppina
- 通讯作者:Candore,Giuseppina
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Arne Akbar其他文献
Time-restricted eating reveals a “younger” immune system and reshapes the intestinal microbiome in human
- DOI:
10.1016/j.redox.2024.103422 - 发表时间:
2024-12-01 - 期刊:
- 影响因子:
- 作者:
Yiran Chen;Xi Li;Ming Yang;Chen Jia;Zhenghao He;Suqing Zhou;Pinglang Ruan;Yikun Wang;Congli Tang;Wenjing Pan;Hai Long;Ming Zhao;Liwei Lu;Weijun Peng;Arne Akbar;Irene XY. Wu;Song Li;Haijing Wu;Qianjin Lu - 通讯作者:
Qianjin Lu
Immunosenescence and Cytomegalovirus: where do we stand after a decade?
- DOI:
10.1186/1742-4933-7-13 - 发表时间:
2010-09-07 - 期刊:
- 影响因子:5.600
- 作者:
Graham Pawelec;Arne Akbar;Peter Beverley;Calogero Caruso;Evelyna Derhovanessian;Tamas Fülöp;Paul Griffiths;Beatrix Grubeck-Loebenstein;Klaus Hamprecht;Gerhard Jahn;Florian Kern;Sven D Koch;Anis Larbi;Andrea B Maier;Derek Macallan;Paul Moss;Sandrine Samson;Jan Strindhall;Emanuelle Trannoy;Mark Wills - 通讯作者:
Mark Wills
Arne Akbar的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Arne Akbar', 18)}}的其他基金
Mechanism for CD8+ T cell recognition and removal of senescent tissue cells during ageing
衰老过程中CD8 T细胞识别和清除衰老组织细胞的机制
- 批准号:
BB/Y003365/1 - 财政年份:2024
- 资助金额:
$ 93.31万 - 项目类别:
Research Grant
Establishing a network to catalyse collaboration for reducing immune ageing (CARINA: CAtalyst Reducing ImmuNe Ageing)
建立网络以促进合作以减少免疫衰老(CARINA:CATalyst Reducing ImmuNe Ageing)
- 批准号:
BB/W018225/1 - 财政年份:2022
- 资助金额:
$ 93.31万 - 项目类别:
Research Grant
How does blocking inflammation enhance human cutaneous immunity during ageing in vivo?
阻断炎症如何增强体内衰老过程中的人体皮肤免疫力?
- 批准号:
MR/T030534/1 - 财政年份:2020
- 资助金额:
$ 93.31万 - 项目类别:
Research Grant
Characterization of Leishmania-Specific T cells in human skin and blood during cutaneous and mucocutaneous leishmaniasis
皮肤和粘膜皮肤利什曼病期间人体皮肤和血液中利什曼原虫特异性 T 细胞的表征
- 批准号:
MR/N017749/1 - 财政年份:2016
- 资助金额:
$ 93.31万 - 项目类别:
Research Grant
The integration of human T cell senescence and function at the molecular level
人类T细胞衰老与功能在分子水平上的整合
- 批准号:
MR/P00184X/1 - 财政年份:2016
- 资助金额:
$ 93.31万 - 项目类别:
Research Grant
MICA: Suppressing inflammation to enhance antigen-specific immunity in older humans using p38MAPK inhibitors and vitaminD3
MICA:使用 p38MAPK 抑制剂和维生素 D3 抑制炎症以增强老年人的抗原特异性免疫力
- 批准号:
MR/M003833/1 - 财政年份:2015
- 资助金额:
$ 93.31万 - 项目类别:
Research Grant
The functional and migratory characteristics of low avidity virus-specific T cells during ageing
衰老过程中低亲和力病毒特异性T细胞的功能和迁移特征
- 批准号:
BB/L005336/1 - 财政年份:2014
- 资助金额:
$ 93.31万 - 项目类别:
Research Grant
International Partnering Award with the USA to investigate signalling pathways that regulate human immunity during ageing
与美国合作研究在衰老过程中调节人体免疫力的信号通路
- 批准号:
BB/L025302/1 - 财政年份:2014
- 资助金额:
$ 93.31万 - 项目类别:
Research Grant
Reversing senescence and exhaustion signalling pathways in primary human T lymphocytes during ageing
逆转衰老过程中人原代 T 淋巴细胞的衰老和耗竭信号通路
- 批准号:
BB/J006750/1 - 财政年份:2012
- 资助金额:
$ 93.31万 - 项目类别:
Research Grant
Mechanisms of reduced T cell imunity in older adults
老年人 T 细胞免疫力降低的机制
- 批准号:
BB/H020519/1 - 财政年份:2010
- 资助金额:
$ 93.31万 - 项目类别:
Research Grant
相似国自然基金
长链非编码RNA Malat1通过PTEN/TCF-1促进记忆CD8+ T细胞分化的机
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
细胞凋亡抑制蛋白2通过激活PPAR通路促进黑色素瘤中CD8+ T细胞脂肪酸代谢及抗肿瘤效应的机制研究
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
MHC-E限制性CD8+调节性T细胞抑制抗肿
瘤免疫反应的机制研究
- 批准号:
- 批准年份:2025
- 资助金额:10.0 万元
- 项目类别:省市级项目
防白颗粒抑制 CD8+ T 细胞自身免疫记忆防治白癜风复发的机制研究
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
天然免疫训练对CD8+ T细胞应答的调节在预防病毒感染中的作用和机制研究
- 批准号:JCZRYB202500527
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
Hsa-miR-126-3p调控的TOPBP1/TICRR通过PD-1/PD-L1抑制CD8+ T细胞促进肝癌进展
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
YTHDF3通过mTORC1驱动前列腺癌细胞脂
代谢重编程介导CD8+ T细胞耗竭的机制
研究
- 批准号:
- 批准年份:2025
- 资助金额:10.0 万元
- 项目类别:省市级项目
E3泛素化连接酶RNF19A通过基底细胞诱导CD8+ T细胞衰竭促进前列腺癌进展的机制研究
- 批准号:2025JJ81003
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
转录因子Twist1调控罗非鱼CD8+ T细胞抵御杀鱼爱德华氏菌感染的机制
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
NK-EVs递送miR-21-5p逆转TGF-β/SMAD
介导的ACLF循环CD8+ T细胞耗竭
- 批准号:
- 批准年份:2025
- 资助金额:10.0 万元
- 项目类别:省市级项目
相似海外基金
Immunomodulatory effects of bortezomib on antitumor CD8 T-NK cell crosstalk
硼替佐米对抗肿瘤 CD8 T-NK 细胞串扰的免疫调节作用
- 批准号:
9770536 - 财政年份:2013
- 资助金额:
$ 93.31万 - 项目类别:
Anergizing effect of NK cell receptor expression on HIV-specific CD8+ T cells
NK 细胞受体表达对 HIV 特异性 CD8 T 细胞的失活作用
- 批准号:
7900192 - 财政年份:2009
- 资助金额:
$ 93.31万 - 项目类别:
Regulation of CD8+ T cell responses via liver NK-DC crosstalk
通过肝脏 NK-DC 串扰调节 CD8 T 细胞反应
- 批准号:
7746094 - 财政年份:2009
- 资助金额:
$ 93.31万 - 项目类别:
NK cells as the missing link between anti-cancer chemotherapy and CD8 T cell responses
NK 细胞是抗癌化疗和 CD8 T 细胞反应之间缺失的环节
- 批准号:
nhmrc : 513804 - 财政年份:2008
- 资助金额:
$ 93.31万 - 项目类别:
NHMRC Project Grants
Expansion of inhibitory NK cell receptor-expressing CD8 T cells and immunoregulatory CD4 T cells
表达抑制性 NK 细胞受体的 CD8 T 细胞和免疫调节性 CD4 T 细胞的扩增
- 批准号:
19591093 - 财政年份:2007
- 资助金额:
$ 93.31万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Anergizing effect of NK cell receptor expression on HIV-specific CD8+ T cells
NK 细胞受体表达对 HIV 特异性 CD8 T 细胞的失活作用
- 批准号:
7619062 - 财政年份:2006
- 资助金额:
$ 93.31万 - 项目类别:
Aspects of CD8+ T cell and NK cell recognition that impact on MHC class I associations with HIV-1 disease progression
CD8 T 细胞和 NK 细胞识别影响 MHC I 类与 HIV-1 疾病进展的关联
- 批准号:
G0501011/1 - 财政年份:2006
- 资助金额:
$ 93.31万 - 项目类别:
Research Grant
Anergizing effect of NK cell receptor expression on HIV-specific CD8+ T cells
NK 细胞受体表达对 HIV 特异性 CD8 T 细胞的失活作用
- 批准号:
7224589 - 财政年份:2006
- 资助金额:
$ 93.31万 - 项目类别:
Anergizing effect of NK cell receptor expression on HIV-specific CD8+ T cells
NK 细胞受体表达对 HIV 特异性 CD8 T 细胞的失活作用
- 批准号:
7558352 - 财政年份:2006
- 资助金额:
$ 93.31万 - 项目类别:
KIR and the Role of CD8 in NK Cell Function
KIR 和 CD8 在 NK 细胞功能中的作用
- 批准号:
6915448 - 财政年份:2005
- 资助金额:
$ 93.31万 - 项目类别:














{{item.name}}会员




